Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Receivables - Net (2022 - 2025)

Historic Receivables - Net for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $75.9 million.

  • Immunocore Holdings' Receivables - Net rose 1922.9% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 1922.9%. This contributed to the annual value of $63.0 million for FY2024, which is 2095.48% up from last year.
  • As of Q3 2025, Immunocore Holdings' Receivables - Net stood at $75.9 million, which was up 1922.9% from $69.8 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Receivables - Net peaked at $75.9 million during Q3 2025, and registered a low of $7.3 million during Q4 2021.
  • For the 5-year period, Immunocore Holdings' Receivables - Net averaged around $54.6 million, with its median value being $61.6 million (2024).
  • Per our database at Business Quant, Immunocore Holdings' Receivables - Net skyrocketed by 35792.2% in 2022 and then soared by 925.65% in 2025.
  • Over the past 5 years, Immunocore Holdings' Receivables - Net (Quarter) stood at $7.3 million in 2021, then skyrocketed by 357.92% to $33.6 million in 2022, then soared by 55.11% to $52.1 million in 2023, then rose by 20.95% to $63.0 million in 2024, then rose by 20.46% to $75.9 million in 2025.
  • Its Receivables - Net was $75.9 million in Q3 2025, compared to $69.8 million in Q2 2025 and $63.1 million in Q1 2025.